FRIENDLY REMINDER: AMBU CAPITAL MARKETS DAY 2025

This is a friendly reminder to secure your seat for in-person attendance at Ambu’s Capital Markets Day, taking place on 1 October 2025 from 10:00 to 16:30 CEST at our headquarters in Denmark, Baltorpbakken 13, 2750 Ballerup.
We look forward to welcoming institutional investors, analysts, and financial media for a day of insights on strategy and market opportunities. Furthermore, it is an opportunity to meet with the broader Executive Leadership Team, as well as key external speakers. Finally, there will be a product demonstration at the end of the event, offering participants the opportunity to experience Ambu’s solutions firsthand.
All presentations and Q&As are held from 10:00-15:00 CEST. The presentations will be held in English, and they will be recorded. After the event, the recorded presentations and the presentation materials will be published on Ambu’s website.
The product demonstration will run from 15:00-16:30 CEST and will be for in-person attendees only.
SIGN UP FOR IN-PERSON ATTENDANCE
We encourage you to sign up for in-person attendance now by writing directly to Louise Alstrup, Executive Assistant.
Please register your in-person attendance no later than Friday 19 September 2025.
Due to capacity constraints, please note that institutional investors, stock analysts, and financial media are given in-person attendance priority to the event. Private investors are encouraged to follow the event online.
FOLLOW THE EVENT ONLINE
Ambu’s Capital Markets Day 2025 will be broadcasted live, and a video streaming link will be added to the Investor Relations site on the company’s website prior to the event.
Please note that online attendees will not be able to ask questions during the Q&A sessions. In addition, the product demonstration from 15:00-16:30 CEST will not be livestreamed during the event. Instead, it will take place for in-person attendees only.
We look forward to seeing you at Ambu’s Capital Markets Day 2025.
Kind regards,
Anders Hjort, Head of Investor Relations
Tine Bjørn Schmidt, Director of Corporate Communications
Frederik Futtrup, Associate, Investor Relations
Keywords
Contacts
Anders HjortHead of Investor Relations
Tel:+45 2892 8881anhj@ambu.comTine Bjørn SchmidtDirector of Corporate Communications
Tel:+45 2264 0697tisc@ambu.comDocuments
Subscribe to releases from Ambu A/S
Subscribe to all the latest releases from Ambu A/S by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Ambu A/S
AMBU APPOINTS NEW PRESIDENT OF NORTH AMERICA REGION22.8.2025 07:10:00 CEST | Press release
Steven Block steps down; Scott Heinzelman appointed as new President to drive Ambu’s strong growth trajectory in North America.
AMBU CAPITAL MARKETS DAY 20257.8.2025 15:25:11 CEST | Press release
Ambu invites institutional investors, analysts, and financial media to the company’s Capital Markets Day on Wednesday 1 October 2025.
AMBU OBTAINS FDA CLEARANCE FOR FIRST-EVER SINGLE-USE FLEXIBLE CYSTO-NEPHROSCOPY SOLUTION19.6.2025 16:43:47 CEST | Press release
The FDA clearance for the Ambu® aScope™ 5 Cysto HD marks a historic milestone as the first ever single-use cysto-nephroscope to receive such clearance in the US. It follows the CE mark in Europe earlier this year, representing an important step forward in endoscopic technology and reinforcing Ambu’s commitment to innovation and advancement in urology care.
AMBU LAUNCHES FIRST-OF-ITS-KIND ENDOSCOPE RECYCLING PROGRAM TO ENHANCE WASTE REDUCTION IN HOSPITALS2.6.2025 10:27:09 CEST | Press release
Today, Ambu announces the launch of its new Ambu® Recircle program, teaming up with hospitals in both the US and the UK as the first key participants.
AMBU® SURESIGHT™ CONNECT VIDEO LARYNGOSCOPE EXPANDS WITH PAEDIATRIC BLADE OPTIONS12.5.2025 16:44:13 CEST | Press release
Ambu has expanded its newly launched Ambu® SureSight™ Connect video laryngoscopy solution with the introduction of five new blades designed specifically for paediatric patients.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom